Optimizing Treatment of Chronic Lymphocytic Leukemia

Learning Objectives:

• Identify key factors to consider when selecting treatment for patients with chronic lymphocytic leukemia (CLL)
• Apply current guidelines to frontline treatment and treatment of relapsed/refractory CLL
• Explain the importance of minimal residual disease in evaluating response
• Describe the advanced practitioner’s role in the prevention, mitigation, and management of adverse events